PTAB To Scrutinize Hedge Fund's Use Of AIA Review Program
The Patent Trial and Appeal Board is taking a close look at a hedge fund's attempt to invalidate a Shire PLC drug patent, requesting more information Tuesday on whether two of...To view the full article, register now.
Already a subscriber? Click here to view full article